It is important to note that the first dose level (50 mill cells) is 11% of the final dose escalation level (450 mill cells).
If CDH17 kills the tumour at the lowest dose level (which was more about minimising the risk of toxicity to the first patients), then imagine what the efficacy will be like if we increase the dose by 9 times!!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.323M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $26.66K | 8.722M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 72 | 71177716 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 94220096 | 28 |
View Market Depth
| Last trade - 14.10pm 28/07/2025 (20 minute delay) ? |
| CHM (ASX) Chart |